These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 7092979
1. Effect of danazol on plasma lipid and lipoprotein levels in normal women. Luciano AA, Wallace RB, Sherman BM. Atherosclerosis; 1982 May; 43(1):133-7. PubMed ID: 7092979 [Abstract] [Full Text] [Related]
2. Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis. Luciano AA, Hauser KS, Chapler FK, Davis WA, Wallace RB. Am J Obstet Gynecol; 1983 Feb 15; 145(4):422-6. PubMed ID: 6824034 [Abstract] [Full Text] [Related]
3. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis. Schweppe KW, Assmann G. Horm Metab Res; 1984 Nov 15; 16(11):593-7. PubMed ID: 6510890 [Abstract] [Full Text] [Related]
4. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women. Fåhraeus L, Larsson-Cohn U, Ljungberg S, Wallentin L. Fertil Steril; 1984 Jul 15; 42(1):52-7. PubMed ID: 6724013 [Abstract] [Full Text] [Related]
5. [Effects of danazol on serum lipid and lipoprotein levels in patients with endometriosis]. Fukuda Y, Tamura S. Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun 15; 39(6):980-6. PubMed ID: 3611874 [Abstract] [Full Text] [Related]
6. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis. Välimäki M, Nilsson CG, Roine R, Ylikorkala O. J Clin Endocrinol Metab; 1989 Dec 15; 69(6):1097-103. PubMed ID: 2531153 [Abstract] [Full Text] [Related]
7. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis. Telimaa S, Penttilä I, Puolakka J, Rönnberg L, Kauppila A. Fertil Steril; 1989 Jul 15; 52(1):31-5. PubMed ID: 2526031 [Abstract] [Full Text] [Related]
8. [Lipoprotein changes during hormonal treatment of endometriosis with lynestrenol and danazol]. Teichmann AT, Wieland H, Cremer P, Kuhn W, Seidel D. Geburtshilfe Frauenheilkd; 1984 Mar 15; 44(3):171-6. PubMed ID: 6562983 [Abstract] [Full Text] [Related]
9. Effects of danazol and lynestrenol on serum lipoproteins in endometriosis. Mälkönen M, Manninen V, Hirvonen E. Clin Pharmacol Ther; 1980 Nov 15; 28(5):602-4. PubMed ID: 7438678 [Abstract] [Full Text] [Related]
10. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors. Crook D, Gardner R, Worthington M, Nolan J, Stevenson JC, Shaw RW. Horm Res; 1989 Nov 15; 32 Suppl 1():157-60. PubMed ID: 2533147 [Abstract] [Full Text] [Related]
13. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Atherosclerosis; 1992 Jan 15; 92(1):41-7. PubMed ID: 1533522 [Abstract] [Full Text] [Related]
14. Cholesterol, high density lipoprotein and danazol. Allen JK, Fraser IS. J Clin Endocrinol Metab; 1981 Jul 15; 53(1):149-52. PubMed ID: 7240372 [Abstract] [Full Text] [Related]
15. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis. Dlugi AM, Rufo S, D'Amico JF, Seibel MM. Fertil Steril; 1988 May 15; 49(5):913-6. PubMed ID: 3129319 [Abstract] [Full Text] [Related]
16. Danazol and plasma lipoprotein metabolism. Shepherd J. Int J Gynaecol Obstet; 1995 Sep 15; 50 Suppl 1():S23-6. PubMed ID: 8529771 [Abstract] [Full Text] [Related]
17. Plasma lipoproteins during and after danazol treatment. Fåhraeus L, Larsson-Cohn U, Ljungberg S, Wallentin L. Acta Obstet Gynecol Scand Suppl; 1984 Sep 15; 123():133-5. PubMed ID: 6594004 [Abstract] [Full Text] [Related]
18. Influence of danazol on uterine activity. A pilot study. Akerlund M. Acta Obstet Gynecol Scand Suppl; 1984 Sep 15; 123():103-6. PubMed ID: 6593998 [Abstract] [Full Text] [Related]
19. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. Bershad S, Rubinstein A, Paterniti JR, Le NA, Poliak SC, Heller B, Ginsberg HN, Fleischmajer R, Brown WV. N Engl J Med; 1985 Oct 17; 313(16):981-5. PubMed ID: 2931603 [Abstract] [Full Text] [Related]